Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 29477-83-6 Chemical Structure| 29477-83-6

Structure of Narciclasine
CAS No.: 29477-83-6

Chemical Structure| 29477-83-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Narciclasine is a plant growth modulator. Narciclasine modulates the Rho/Rho kinase/LIM kinase/cofilin signaling pathway, greatly increasing GTPase RhoA activity as well as inducing actin stress fiber formation in a RhoA-dependent manner.

Synonyms: Lycoricidinol; (+)-Narciclasine; NSC 266535

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Narciclasine

CAS No. :29477-83-6
Formula : C14H13NO7
M.W : 307.26
SMILES Code : O=C1N[C@@]2([H])[C@H](O)[C@H](O)[C@@H](O)C=C2C3=C1C(O)=C4C(OCO4)=C3
Synonyms :
Lycoricidinol; (+)-Narciclasine; NSC 266535
MDL No. :MFCD01729949

Safety of Narciclasine

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301
Precautionary Statements:P264-P270-P301+P310-P321-P330-P405-P501
Class:6.1
UN#:2811
Packing Group:

Related Pathways of Narciclasine

cytoskeleton

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Yeast strain SAN006 0.1 mM Assess cytotoxicity of sanguinarine Genes Dis. 2023 Apr 13;11(5):100938.
MDA-MB-231 breast cancer cells 1 µM 24 hours Induced DNA laddering Neoplasia. 2007 Sep;9(9):766-76.
CoN 1.1 µM (IC50) 72 hours Inhibited cell proliferation with IC50 of 1.1 μM Biomolecules. 2022 Sep 9;12(9):1267.
DLD-1 0.030 µM (IC50) 72 hours Inhibited cell proliferation with IC50 of 0.030 μM Biomolecules. 2022 Sep 9;12(9):1267.
HCT-116 0.052 µM (IC50) 72 hours Inhibited cell proliferation with IC50 of 0.052 μM Biomolecules. 2022 Sep 9;12(9):1267.
HT-29 0.032 µM (IC50) 72 hours Inhibited cell proliferation with IC50 of 0.032 μM Biomolecules. 2022 Sep 9;12(9):1267.
LoVo 0.023 µM (IC50) 72 hours Inhibited cell proliferation with IC50 of 0.023 μM Biomolecules. 2022 Sep 9;12(9):1267.
Ccd-25-Lu normal lung fibroblasts 1 µM 18 hours No marked apoptotic morphological changes induced Neoplasia. 2007 Sep;9(9):766-76.
PC-3 prostate cancer cells 1 µM 18 hours Induced marked apoptotic morphological changes and loss of mitochondrial membrane potential Neoplasia. 2007 Sep;9(9):766-76.
MCF-7 breast cancer cells 1 µM 18 hours Induced marked apoptotic morphological changes and loss of mitochondrial membrane potential Neoplasia. 2007 Sep;9(9):766-76.
Tobacco BY-2 cells 0.5 and 5.0 µM 2 days To study the effects of NCS on cell cycle progression, results showed that NCS inhibits cell division and affects the expression of cell cycle genes. BMC Plant Biol. 2011 Dec 28;11:184.
HCC-1937 50 nM 24 hours To evaluate the inhibitory effect of Narciclasine on HCC-1937 cell proliferation and its ability to induce autophagy-dependent apoptosis Cell Prolif. 2018 Dec;51(6):e12518.
MCF-7/TR cells 100 nM 24 hours Specifically degraded total STAT3 via the proteasome pathway Mol Ther Oncolytics. 2022 Jan 3;24:340-354.
MCF-7 cells 100 nM 24 hours Suppressed phosphorylation, activation, dimerization, and nuclear translocation of STAT3 Mol Ther Oncolytics. 2022 Jan 3;24:340-354.
IMG cells 50 nM 24 hours To evaluate the effect of Narciclasine on LPS-induced inflammatory response. Results showed that Narciclasine alone did not induce inflammatory response but exacerbated inflammation when combined with LPS. Cells. 2023 May 11;12(10):1367.
BSC-1 cells 40-320 nM 24 hours To evaluate the inhibitory effect of Narciclasine on VACV viral protein expression in BSC-1 cells, showing a dose-dependent decrease in viral protein levels. Biosaf Health. 2024 Nov 19;6(6):341-349.
Huh7.5.1 cells 40-320 nM 24 hours To evaluate the cytotoxicity of Narciclasine on Huh7.5.1 cells, showing a slight reduction in cell viability starting from 80 nM. Biosaf Health. 2024 Nov 19;6(6):341-349.
HeLa cells 40-320 nM 24 hours To evaluate the cytotoxicity of Narciclasine on HeLa cells, showing no significant effect on cell viability at ≤320 nM. Biosaf Health. 2024 Nov 19;6(6):341-349.
36C15Q cells 20 nM 48 hours Promotes oxidative metabolism gene expression, reduces lipid accumulation PLoS Biol. 2017 Feb 16;15(2):e1002597.
C2C12 cells 20 nM 48 hours Promotes oxidative metabolism gene expression, reduces lipid accumulation PLoS Biol. 2017 Feb 16;15(2):e1002597.
Arabidopsis root tip cells 0.5 and 5.0 µM 6 to 48 hours To analyze the effects of NCS on the expression of core cell cycle genes, results showed that NCS disturbs the expression of G1/S and G2/M phase genes. BMC Plant Biol. 2011 Dec 28;11:184.
Neonatal rat cardiomyocytes (NRCMs) 0, 30, 100, and 300 nM To evaluate the effect of Narciclasine on LPS-induced inflammation in cardiomyocytes. Results showed that Narciclasine attenuated LPS-induced decrease in cell viability in a dose-dependent manner, suppressed inflammatory cytokine (TNF-α, IL-1β, and IL-6) release, and reduced apoptosis. Aging (Albany NY). 2021 May 25;13(11):15151-15163.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice LPS-induced acute myocardial injury model Gavage 0.1 mg/kg Once daily for 7 days To investigate the protective effect of Narciclasine on LPS-induced myocardial injury. Results showed that Narciclasine partly improved cardiac function parameters (e.g., LVEF and LVFS), increased survival rates, and reduced inflammatory indicators (e.g., MPO and cytokines IL-6, IL-1β, TNF-α, VEGF). Aging (Albany NY). 2021 May 25;13(11):15151-15163.
Neonatal rats E. coli-induced sepsis model Intraperitoneal injection 0.1 mg/kg, 1 mg/kg, 3 mg/kg Administered 1 hour after sepsis induction, observed for 30 hours Narciclasine significantly reduced mortality in neonatal rats with sepsis, alleviated clinical sepsis symptoms, reduced bacterial load, decreased levels of inflammatory cytokines, inhibited the expression of S100A8/A9, alleviated inflammation and injury in liver and lungs, improved hematological parameters, and suppressed the activation of the NF-κB signaling pathway. Sci Rep. 2020 Feb 19;10(1):2947
Arabidopsis Arabidopsis seedlings Medium treatment 0.1, 0.5, 1.0 and 5.0 μM Continuous treatment for 7 days To study the inhibitory effects of NCS on Arabidopsis root growth, results showed that NCS significantly inhibited root growth and lateral root density. BMC Plant Biol. 2011 Dec 28;11:184.
Sprague-Dawley rats LPS-induced neonatal acute lung injury model Subcutaneous injection 0.7 mg/kg Administered 12 hours prior to LPS exposure, lasting for 72 hours Narciclasine attenuated LPS-induced pathological injury and pulmonary edema, suppressed the secretion of inflammatory cytokines, alleviated oxidative stress and apoptosis, and exerted protective effects by inhibiting the activation of the TLR4/NF-κB/Cox2 signaling pathway. Bioengineered. 2020 Dec;11(1):801-810
Mice High-fat diet-induced obesity model Oral gavage 1 mg/kg Weekly for seven consecutive weeks Attenuates obesity, promotes energy expenditure, improves metabolic parameters PLoS Biol. 2017 Feb 16;15(2):e1002597.
BALB/c-nu mice MCF-7 xenograft model Intraperitoneal injection 1 mg/kg Every 2 days for 4 weeks Significantly reduced tumor size and weight, decreased STAT3 phosphorylation levels Mol Ther Oncolytics. 2022 Jan 3;24:340-354.
BALB/c nude mice HCC1937 TNBC xenograft model Oral 2 or 5 mg/kg Three times per week for 21 days To evaluate the inhibitory effect of Narciclasine on HCC1937 TNBC xenograft tumor growth and its mechanism Cell Prolif. 2018 Dec;51(6):e12518.
BALB/C mice IMQ-induced psoriasis-like dermatitis model Intradermal injection 2mg/kg Once daily for 6 days To evaluate the therapeutic effect of Ncs on IMQ-induced psoriasis-like dermatitis, results showed that Ncs significantly improved skin lesions, reduced epidermal thickening and immune cell infiltration. Front Immunol. 2023 Jan 4;13:1094375

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.25mL

0.65mL

0.33mL

16.27mL

3.25mL

1.63mL

32.55mL

6.51mL

3.25mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories